ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

VELPHORO
Hyperphosphatemia
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

VELPHORO Rx

Generic Name and Formulations:
Sucroferric oxyhydroxide 500mg; chew tabs.

Company:
Fresenius Medical Care North America

Therapeutic Use:

Indications for VELPHORO:

For control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Adult:

Chew, do not swallow whole. Take with meals. Initially 500mg 3 times daily; monitor serum phosphorus levels and titrate dose in decrements or increments of 500mg/day as needed until acceptable serum phosphorus level reached. May titrate as often as weekly.

Children:

Not established.

Warnings/Precautions:

GI, hepatic, or iron accumulation disorders; monitor effect and iron homeostasis. Pregnancy (Cat.B).

Pharmacological Class:

Phosphate binder.

Interactions:

Separate dosing of doxycycline, acetylsalicylic acid, cephalexin by ≥1hr before Velphoro; levothyroxine by ≥4hrs before. Concomitant drugs with narrow therapeutic index; monitor.

Adverse Reactions:

Discolored feces, diarrhea, nausea.

How Supplied:

Chew tabs—90

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs